English
简体中文
Total: £ 56.28
Published Date: 2026-01-30 | Pages: 151 | Tables: 152 | Pharma & Healthcare
The global Pharmaceutical Grade Melatonin Products market was valued at US$ 1192 million in 2025 and is anticipated to reach US$ 1865 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Melatonin Products competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Pharmaceutical Grade Melatonin Products production reached approximately 55.85 million units , with an average global market price of around US$ 20 per unit.
Pharmaceutical-grade melatonin products are prescription drugs or high-standard pharmaceutical preparations made from melatonin raw materials produced in accordance with pharmaceutical standards (such as USP, EP, BP, etc.) and GMP regulations. These include sustained-release tablets, immediate-release tablets, microcapsules, oral liquids, sprays, and hospital-prepared formulations, used to treat or assist in the treatment of insomnia, circadian rhythm disorders, sleep disorders in the elderly, and insomnia related to autism spectrum disorder (ASD) and neurogenetic diseases in some children. Representative products include Neurim/Aspen's sustained-release tablets Circadin and children's sustained-release tablets Slenyto, as well as various generic or branded melatonin preparations marketed by companies such as Aspen Pharmacare, AGB-Pharma, Alturix, Pharma Nord, Teva, and Mylan. Compared to ordinary food-grade or dietary supplements, pharmaceutical-grade products adhere to stricter drug regulatory requirements regarding raw material purity, impurity profile control, dissolution and sustained-release profiles, bioequivalence, stability testing, and evidence of clinical efficacy and safety. They are often dispensed as prescription drugs in hospitals, pharmacies, or after online consultations with doctors/pharmacies.
From an industry chain perspective, the upstream of pharmaceutical-grade melatonin products mainly consists of melatonin API and excipient suppliers that meet USP/EP/BP standards, including Swati Spentose, Biophore India, and Laurus Labs in India, and Huanggang Saikang (Nutrakey system) and Sichuan Benepure in China. These suppliers provide pharmaceutical-grade melatonin and excipients with a purity of 98–99.9% through pharmacopoeia standards, DMF/ASMF, EU-WC, and other systems. The midstream is handled by pharmaceutical companies specializing in neuroscience and sleep, such as Neurim Pharmaceuticals, AGB-Pharma, Alturix, Teva, and Mylan, which develop formulations and manufacture pharmaceutical products, forming extended-release tablets, pediatric formulations, and generic drugs for various countries. The downstream is provided to end patients through hospital prescriptions, community pharmacies, public health insurance catalogs, and compliant online consultation platforms for the treatment of chronic insomnia in the elderly, ASD/NGD-related insomnia in children, and jet lag syndrome. Some high-standard dietary supplement brands also use pharmaceutical-grade melatonin. APIs are sold to physicians and functional medicine clinics. Overall, the high degree of specialization and international certification requirements on the raw material side, the sustained-release technology and pediatric-specific dosage form development on the formulation side, and the regulatory and reimbursement policies of various countries downstream, together determine the positioning and profit model of pharmaceutical-grade melatonin products between "pharmaceuticals" and "high-end nutritional products".
The annual production capacity of a single-line Pharmaceutical Grade Melatonin Products is approximately 500k units, with a gross profit margin of approximately 55%-70%.
Overall, pharmaceutical grade melatonin products occupy a niche, higher-end position between conventional hypnotic drugs and over-the-counter melatonin supplements, combining physician-led, evidence-based use with growing public awareness of sleep health. Thanks to a more favourable profile in terms of dependence, safety and tolerability during long-term use, prolonged-release melatonin has gradually been incorporated into clinical guidelines and expert recommendations in many countries for older adults with chronic insomnia, patients with circadian rhythm disorders and children with neurodevelopmental conditions associated with sleep difficulties, creating a relatively stable base of prescription demand. On the supply side, originator products and a small group of companies with strong modified-release and pediatric-formulation capabilities still enjoy notable barriers to entry in several markets, but as patents and data-exclusivity periods expire, generic competitors are entering, intensifying price competition while also broadening the range of dosage forms and dosing strategies available. Regionally, some European and Commonwealth countries are leveraging prescription and reimbursement channels to drive uptake, North America shows a mix of prescription use and high-standard OTC positioning, and emerging markets are gradually opening as regulatory frameworks become clearer. In summary, pharmaceutical grade melatonin products are likely to sustain growth that outpaces traditional hypnotics but is somewhat more measured than that of the broader melatonin supplement category, functioning primarily as relatively safe, long-term sleep and circadian-management tools within medical channels, clearly differentiated in branding and regulation from ordinary melatonin nutraceuticals.
This report delivers a comprehensive overview of the global Pharmaceutical Grade Melatonin Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Grade Melatonin Products. The Pharmaceutical Grade Melatonin Products market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Grade Melatonin Products market comprehensively. Regional market sizes by Type, by Application, by Source, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Grade Melatonin Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Church & Dwight
Pfizer
Solgar
Biotics Research
Now Food
Neurim Pharmaceuticals
Slenyto
Nature Made
Centrum
Vitafusion
CVS Health
Leosons Corporation
Zahler
Mauricettes
AGB-Pharma
Alturix
Pharma Nord
Teva
Mylan
Xiu Zheng
By-Health
Conba Pharm
Meiaojian Biotechnology
Segment by Type
Tablets
Oral Solution
Segment by Source
Natural Melatonin
Synthetic Melatonin
Segment by Dosage Forms
Immediate-Release Tablets
Sustained-Release Tablets
by Application
Hospital and Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Grade Melatonin Products manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pharmaceutical Grade Melatonin Products sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pharmaceutical Grade Melatonin Products Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Melatonin Products by Type
1.2.1 Global Pharmaceutical Grade Melatonin Products Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Oral Solution
1.3 Pharmaceutical Grade Melatonin Products by Source
1.3.1 Global Pharmaceutical Grade Melatonin Products Market Value by Source: 2025 vs 2032
1.3.2 Natural Melatonin
1.3.3 Synthetic Melatonin
1.4 Pharmaceutical Grade Melatonin Products by Dosage Forms
1.4.1 Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms: 2025 vs 2032
1.4.2 Immediate-Release Tablets
1.4.3 Sustained-Release Tablets
1.5 Pharmaceutical Grade Melatonin Products by Application
1.5.1 Global Pharmaceutical Grade Melatonin Products Market Value by Application: 2025 vs 2032
1.5.2 Hospital and Clinic
1.5.3 Pharmacy
1.5.4 Other
1.6 Global Pharmaceutical Grade Melatonin Products Market Size Estimates and Forecasts
1.6.1 Global Pharmaceutical Grade Melatonin Products Revenue 2021–2032
1.6.2 Global Pharmaceutical Grade Melatonin Products Sales 2021–2032
1.6.3 Global Pharmaceutical Grade Melatonin Products Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Pharmaceutical Grade Melatonin Products Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pharmaceutical Grade Melatonin Products Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pharmaceutical Grade Melatonin Products, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Product Types and Applications
2.7 Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Date of Entry into the Industry
2.8 Global Pharmaceutical Grade Melatonin Products Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Grade Melatonin Products Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pharmaceutical Grade Melatonin Products Players Market Share by Revenue
2.8.3 Global Pharmaceutical Grade Melatonin Products Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Grade Melatonin Products Market Scenario by Region
3.1 Global Pharmaceutical Grade Melatonin Products Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2021–2032
3.2.1 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2021–2026
3.2.2 Global Pharmaceutical Grade Melatonin Products Sales by Region: 2027–2032
3.3 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2021–2032
3.3.1 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2021–2026
3.3.2 Global Pharmaceutical Grade Melatonin Products Revenue by Region: 2027–2032
3.4 North America Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.4.3 North America Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.5.3 Europe Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Melatonin Products Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Grade Melatonin Products Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (2021–2032)
3.6.3 Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.7.3 Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmaceutical Grade Melatonin Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Melatonin Products Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Melatonin Products Sales by Type (2021–2032)
4.1.1 Global Pharmaceutical Grade Melatonin Products Sales by Type (2021–2026)
4.1.2 Global Pharmaceutical Grade Melatonin Products Sales by Type (2027–2032)
4.1.3 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2021–2032)
4.2 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2021–2032)
4.2.1 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2021–2026)
4.2.2 Global Pharmaceutical Grade Melatonin Products Revenue by Type (2027–2032)
4.2.3 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2021–2032)
4.3 Global Pharmaceutical Grade Melatonin Products Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pharmaceutical Grade Melatonin Products Sales by Application (2021–2032)
5.1.1 Global Pharmaceutical Grade Melatonin Products Sales by Application (2021–2026)
5.1.2 Global Pharmaceutical Grade Melatonin Products Sales by Application (2027–2032)
5.1.3 Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2021–2032)
5.2 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2021–2032)
5.2.1 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2021–2026)
5.2.2 Global Pharmaceutical Grade Melatonin Products Revenue by Application (2027–2032)
5.2.3 Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2021–2032)
5.3 Global Pharmaceutical Grade Melatonin Products Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Natrol
6.1.1 Natrol Company Information
6.1.2 Natrol Description and Business Overview
6.1.3 Natrol Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Natrol Pharmaceutical Grade Melatonin Products Product Portfolio
6.1.5 Natrol Recent Developments/Updates
6.2 Pharmavite
6.2.1 Pharmavite Company Information
6.2.2 Pharmavite Description and Business Overview
6.2.3 Pharmavite Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pharmavite Pharmaceutical Grade Melatonin Products Product Portfolio
6.2.5 Pharmavite Recent Developments/Updates
6.3 Nature's Bounty
6.3.1 Nature's Bounty Company Information
6.3.2 Nature's Bounty Description and Business Overview
6.3.3 Nature's Bounty Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Nature's Bounty Pharmaceutical Grade Melatonin Products Product Portfolio
6.3.5 Nature's Bounty Recent Developments/Updates
6.4 Jameison
6.4.1 Jameison Company Information
6.4.2 Jameison Description and Business Overview
6.4.3 Jameison Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jameison Pharmaceutical Grade Melatonin Products Product Portfolio
6.4.5 Jameison Recent Developments/Updates
6.5 Rexall Sundown
6.5.1 Rexall Sundown Company Information
6.5.2 Rexall Sundown Description and Business Overview
6.5.3 Rexall Sundown Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Rexall Sundown Pharmaceutical Grade Melatonin Products Product Portfolio
6.5.5 Rexall Sundown Recent Developments/Updates
6.6 GNC
6.6.1 GNC Company Information
6.6.2 GNC Description and Business Overview
6.6.3 GNC Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 GNC Pharmaceutical Grade Melatonin Products Product Portfolio
6.6.5 GNC Recent Developments/Updates
6.7 Church & Dwight
6.7.1 Church & Dwight Company Information
6.7.2 Church & Dwight Description and Business Overview
6.7.3 Church & Dwight Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Church & Dwight Pharmaceutical Grade Melatonin Products Product Portfolio
6.7.5 Church & Dwight Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pfizer Pharmaceutical Grade Melatonin Products Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Solgar
6.9.1 Solgar Company Information
6.9.2 Solgar Description and Business Overview
6.9.3 Solgar Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Solgar Pharmaceutical Grade Melatonin Products Product Portfolio
6.9.5 Solgar Recent Developments/Updates
6.10 Biotics Research
6.10.1 Biotics Research Company Information
6.10.2 Biotics Research Description and Business Overview
6.10.3 Biotics Research Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biotics Research Pharmaceutical Grade Melatonin Products Product Portfolio
6.10.5 Biotics Research Recent Developments/Updates
6.11 Now Food
6.11.1 Now Food Company Information
6.11.2 Now Food Description and Business Overview
6.11.3 Now Food Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Now Food Pharmaceutical Grade Melatonin Products Product Portfolio
6.11.5 Now Food Recent Developments/Updates
6.12 Neurim Pharmaceuticals
6.12.1 Neurim Pharmaceuticals Company Information
6.12.2 Neurim Pharmaceuticals Description and Business Overview
6.12.3 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Product Portfolio
6.12.5 Neurim Pharmaceuticals Recent Developments/Updates
6.13 Slenyto
6.13.1 Slenyto Company Information
6.13.2 Slenyto Description and Business Overview
6.13.3 Slenyto Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Slenyto Pharmaceutical Grade Melatonin Products Product Portfolio
6.13.5 Slenyto Recent Developments/Updates
6.14 Nature Made
6.14.1 Nature Made Company Information
6.14.2 Nature Made Description and Business Overview
6.14.3 Nature Made Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Nature Made Pharmaceutical Grade Melatonin Products Product Portfolio
6.14.5 Nature Made Recent Developments/Updates
6.15 Centrum
6.15.1 Centrum Company Information
6.15.2 Centrum Description and Business Overview
6.15.3 Centrum Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Centrum Pharmaceutical Grade Melatonin Products Product Portfolio
6.15.5 Centrum Recent Developments/Updates
6.16 Vitafusion
6.16.1 Vitafusion Company Information
6.16.2 Vitafusion Description and Business Overview
6.16.3 Vitafusion Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Vitafusion Pharmaceutical Grade Melatonin Products Product Portfolio
6.16.5 Vitafusion Recent Developments/Updates
6.17 CVS Health
6.17.1 CVS Health Company Information
6.17.2 CVS Health Description and Business Overview
6.17.3 CVS Health Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 CVS Health Pharmaceutical Grade Melatonin Products Product Portfolio
6.17.5 CVS Health Recent Developments/Updates
6.18 Leosons Corporation
6.18.1 Leosons Corporation Company Information
6.18.2 Leosons Corporation Description and Business Overview
6.18.3 Leosons Corporation Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Leosons Corporation Pharmaceutical Grade Melatonin Products Product Portfolio
6.18.5 Leosons Corporation Recent Developments/Updates
6.19 Zahler
6.19.1 Zahler Company Information
6.19.2 Zahler Description and Business Overview
6.19.3 Zahler Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Zahler Pharmaceutical Grade Melatonin Products Product Portfolio
6.19.5 Zahler Recent Developments/Updates
6.20 Mauricettes
6.20.1 Mauricettes Company Information
6.20.2 Mauricettes Description and Business Overview
6.20.3 Mauricettes Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Mauricettes Pharmaceutical Grade Melatonin Products Product Portfolio
6.20.5 Mauricettes Recent Developments/Updates
6.21 AGB-Pharma
6.21.1 AGB-Pharma Company Information
6.21.2 AGB-Pharma Description and Business Overview
6.21.3 AGB-Pharma Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 AGB-Pharma Pharmaceutical Grade Melatonin Products Product Portfolio
6.21.5 AGB-Pharma Recent Developments/Updates
6.22 Alturix
6.22.1 Alturix Company Information
6.22.2 Alturix Description and Business Overview
6.22.3 Alturix Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Alturix Pharmaceutical Grade Melatonin Products Product Portfolio
6.22.5 Alturix Recent Developments/Updates
6.23 Pharma Nord
6.23.1 Pharma Nord Company Information
6.23.2 Pharma Nord Description and Business Overview
6.23.3 Pharma Nord Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Pharma Nord Pharmaceutical Grade Melatonin Products Product Portfolio
6.23.5 Pharma Nord Recent Developments/Updates
6.24 Teva
6.24.1 Teva Company Information
6.24.2 Teva Description and Business Overview
6.24.3 Teva Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Teva Pharmaceutical Grade Melatonin Products Product Portfolio
6.24.5 Teva Recent Developments/Updates
6.25 Mylan
6.25.1 Mylan Company Information
6.25.2 Mylan Description and Business Overview
6.25.3 Mylan Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Mylan Pharmaceutical Grade Melatonin Products Product Portfolio
6.25.5 Mylan Recent Developments/Updates
6.26 Xiu Zheng
6.26.1 Xiu Zheng Company Information
6.26.2 Xiu Zheng Description and Business Overview
6.26.3 Xiu Zheng Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Xiu Zheng Pharmaceutical Grade Melatonin Products Product Portfolio
6.26.5 Xiu Zheng Recent Developments/Updates
6.27 By-Health
6.27.1 By-Health Company Information
6.27.2 By-Health Description and Business Overview
6.27.3 By-Health Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 By-Health Pharmaceutical Grade Melatonin Products Product Portfolio
6.27.5 By-Health Recent Developments/Updates
6.28 Conba Pharm
6.28.1 Conba Pharm Company Information
6.28.2 Conba Pharm Description and Business Overview
6.28.3 Conba Pharm Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Conba Pharm Pharmaceutical Grade Melatonin Products Product Portfolio
6.28.5 Conba Pharm Recent Developments/Updates
6.29 Meiaojian Biotechnology
6.29.1 Meiaojian Biotechnology Company Information
6.29.2 Meiaojian Biotechnology Description and Business Overview
6.29.3 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Product Portfolio
6.29.5 Meiaojian Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Melatonin Products Industry Chain Analysis
7.2 Pharmaceutical Grade Melatonin Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Melatonin Products Production Mode & Process Analysis
7.4 Pharmaceutical Grade Melatonin Products Sales and Marketing
7.4.1 Pharmaceutical Grade Melatonin Products Sales Channels
7.4.2 Pharmaceutical Grade Melatonin Products Distributors
7.5 Pharmaceutical Grade Melatonin Products Customer Analysis
8 Pharmaceutical Grade Melatonin Products Market Dynamics
8.1 Pharmaceutical Grade Melatonin Products Industry Trends
8.2 Pharmaceutical Grade Melatonin Products Market Drivers
8.3 Pharmaceutical Grade Melatonin Products Market Challenges
8.4 Pharmaceutical Grade Melatonin Products Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Grade Melatonin Products Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Pharmaceutical Grade Melatonin Products Market Value by Source (US$ Million), 2025 vs 2032
Table 3. Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms (US$ Million), 2025 vs 2032
Table 4. Global Pharmaceutical Grade Melatonin Products Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Pharmaceutical Grade Melatonin Products Market Competitive Situation by Manufacturers in 2025
Table 6. Global Pharmaceutical Grade Melatonin Products Sales (K Units) of Key Manufacturers (2021–2026)
Table 7. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Pharmaceutical Grade Melatonin Products Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Pharmaceutical Grade Melatonin Products Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Pharmaceutical Grade Melatonin Products, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Product Types and Applications
Table 14. Global Key Manufacturers of Pharmaceutical Grade Melatonin Products, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Pharmaceutical Grade Melatonin Products Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Grade Melatonin Products Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Pharmaceutical Grade Melatonin Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2021–2026
Table 20. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2021–2026)
Table 21. Global Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2027–2032
Table 22. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2027–2032)
Table 23. Global Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2021–2026
Table 24. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2021–2026)
Table 25. Global Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2027–2032
Table 26. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2027–2032)
Table 27. North America Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
Table 29. North America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
Table 30. North America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
Table 31. North America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
Table 34. Europe Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
Table 35. Europe Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2021–2026
Table 39. Asia Pacific Pharmaceutical Grade Melatonin Products Sales by Region (K Units), 2027–2032
Table 40. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
Table 44. Latin America Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
Table 45. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2021–2026
Table 49. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales by Country (K Units), 2027–2032
Table 50. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue by Country (US$ Million), 2027–2032
Table 52. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Type (2021–2026)
Table 53. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Type (2027–2032)
Table 54. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2021–2026)
Table 55. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Type (2027–2032)
Table 56. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2021–2026)
Table 59. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Type (2027–2032)
Table 60. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2021–2026)
Table 61. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2027–2032)
Table 62. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Application (2021–2026)
Table 63. Global Pharmaceutical Grade Melatonin Products Sales (K Units) by Application (2027–2032)
Table 64. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2021–2026)
Table 65. Global Pharmaceutical Grade Melatonin Products Sales Market Share by Application (2027–2032)
Table 66. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Pharmaceutical Grade Melatonin Products Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2021–2026)
Table 69. Global Pharmaceutical Grade Melatonin Products Revenue Market Share by Application (2027–2032)
Table 70. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2021–2026)
Table 71. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2027–2032)
Table 72. Natrol Company Information
Table 73. Natrol Description and Business Overview
Table 74. Natrol Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Natrol Pharmaceutical Grade Melatonin Products Product
Table 76. Natrol Recent Developments/Updates
Table 77. Pharmavite Company Information
Table 78. Pharmavite Description and Business Overview
Table 79. Pharmavite Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Pharmavite Pharmaceutical Grade Melatonin Products Product
Table 81. Pharmavite Recent Developments/Updates
Table 82. Nature's Bounty Company Information
Table 83. Nature's Bounty Description and Business Overview
Table 84. Nature's Bounty Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Nature's Bounty Pharmaceutical Grade Melatonin Products Product
Table 86. Nature's Bounty Recent Developments/Updates
Table 87. Jameison Company Information
Table 88. Jameison Description and Business Overview
Table 89. Jameison Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Jameison Pharmaceutical Grade Melatonin Products Product
Table 91. Jameison Recent Developments/Updates
Table 92. Rexall Sundown Company Information
Table 93. Rexall Sundown Description and Business Overview
Table 94. Rexall Sundown Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Rexall Sundown Pharmaceutical Grade Melatonin Products Product
Table 96. Rexall Sundown Recent Developments/Updates
Table 97. GNC Company Information
Table 98. GNC Description and Business Overview
Table 99. GNC Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. GNC Pharmaceutical Grade Melatonin Products Product
Table 101. GNC Recent Developments/Updates
Table 102. Church & Dwight Company Information
Table 103. Church & Dwight Description and Business Overview
Table 104. Church & Dwight Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Church & Dwight Pharmaceutical Grade Melatonin Products Product
Table 106. Church & Dwight Recent Developments/Updates
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Business Overview
Table 109. Pfizer Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Pfizer Pharmaceutical Grade Melatonin Products Product
Table 111. Pfizer Recent Developments/Updates
Table 112. Solgar Company Information
Table 113. Solgar Description and Business Overview
Table 114. Solgar Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Solgar Pharmaceutical Grade Melatonin Products Product
Table 116. Solgar Recent Developments/Updates
Table 117. Biotics Research Company Information
Table 118. Biotics Research Description and Business Overview
Table 119. Biotics Research Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Biotics Research Pharmaceutical Grade Melatonin Products Product
Table 121. Biotics Research Recent Developments/Updates
Table 122. Now Food Company Information
Table 123. Now Food Description and Business Overview
Table 124. Now Food Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Now Food Pharmaceutical Grade Melatonin Products Product
Table 126. Now Food Recent Developments/Updates
Table 127. Neurim Pharmaceuticals Company Information
Table 128. Neurim Pharmaceuticals Description and Business Overview
Table 129. Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Neurim Pharmaceuticals Pharmaceutical Grade Melatonin Products Product
Table 131. Neurim Pharmaceuticals Recent Developments/Updates
Table 132. Slenyto Company Information
Table 133. Slenyto Description and Business Overview
Table 134. Slenyto Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. Slenyto Pharmaceutical Grade Melatonin Products Product
Table 136. Slenyto Recent Developments/Updates
Table 137. Nature Made Company Information
Table 138. Nature Made Description and Business Overview
Table 139. Nature Made Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Nature Made Pharmaceutical Grade Melatonin Products Product
Table 141. Nature Made Recent Developments/Updates
Table 142. Centrum Company Information
Table 143. Centrum Description and Business Overview
Table 144. Centrum Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Centrum Pharmaceutical Grade Melatonin Products Product
Table 146. Centrum Recent Developments/Updates
Table 147. Vitafusion Company Information
Table 148. Vitafusion Description and Business Overview
Table 149. Vitafusion Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Vitafusion Pharmaceutical Grade Melatonin Products Product
Table 151. Vitafusion Recent Developments/Updates
Table 152. CVS Health Company Information
Table 153. CVS Health Description and Business Overview
Table 154. CVS Health Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. CVS Health Pharmaceutical Grade Melatonin Products Product
Table 156. CVS Health Recent Developments/Updates
Table 157. Leosons Corporation Company Information
Table 158. Leosons Corporation Description and Business Overview
Table 159. Leosons Corporation Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Leosons Corporation Pharmaceutical Grade Melatonin Products Product
Table 161. Leosons Corporation Recent Developments/Updates
Table 162. Zahler Company Information
Table 163. Zahler Description and Business Overview
Table 164. Zahler Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. Zahler Pharmaceutical Grade Melatonin Products Product
Table 166. Zahler Recent Developments/Updates
Table 167. Mauricettes Company Information
Table 168. Mauricettes Description and Business Overview
Table 169. Mauricettes Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Mauricettes Pharmaceutical Grade Melatonin Products Product
Table 171. Mauricettes Recent Developments/Updates
Table 172. AGB-Pharma Company Information
Table 173. AGB-Pharma Description and Business Overview
Table 174. AGB-Pharma Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. AGB-Pharma Pharmaceutical Grade Melatonin Products Product
Table 176. AGB-Pharma Recent Developments/Updates
Table 177. Alturix Company Information
Table 178. Alturix Description and Business Overview
Table 179. Alturix Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. Alturix Pharmaceutical Grade Melatonin Products Product
Table 181. Alturix Recent Developments/Updates
Table 182. Pharma Nord Company Information
Table 183. Pharma Nord Description and Business Overview
Table 184. Pharma Nord Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. Pharma Nord Pharmaceutical Grade Melatonin Products Product
Table 186. Pharma Nord Recent Developments/Updates
Table 187. Teva Company Information
Table 188. Teva Description and Business Overview
Table 189. Teva Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 190. Teva Pharmaceutical Grade Melatonin Products Product
Table 191. Teva Recent Developments/Updates
Table 192. Mylan Company Information
Table 193. Mylan Description and Business Overview
Table 194. Mylan Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 195. Mylan Pharmaceutical Grade Melatonin Products Product
Table 196. Mylan Recent Developments/Updates
Table 197. Xiu Zheng Company Information
Table 198. Xiu Zheng Description and Business Overview
Table 199. Xiu Zheng Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 200. Xiu Zheng Pharmaceutical Grade Melatonin Products Product
Table 201. Xiu Zheng Recent Developments/Updates
Table 202. By-Health Company Information
Table 203. By-Health Description and Business Overview
Table 204. By-Health Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 205. By-Health Pharmaceutical Grade Melatonin Products Product
Table 206. By-Health Recent Developments/Updates
Table 207. Conba Pharm Company Information
Table 208. Conba Pharm Description and Business Overview
Table 209. Conba Pharm Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 210. Conba Pharm Pharmaceutical Grade Melatonin Products Product
Table 211. Conba Pharm Recent Developments/Updates
Table 212. Meiaojian Biotechnology Company Information
Table 213. Meiaojian Biotechnology Description and Business Overview
Table 214. Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 215. Meiaojian Biotechnology Pharmaceutical Grade Melatonin Products Product
Table 216. Meiaojian Biotechnology Recent Developments/Updates
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Pharmaceutical Grade Melatonin Products Distributors List
Table 220. Pharmaceutical Grade Melatonin Products Customers List
Table 221. Pharmaceutical Grade Melatonin Products Market Trends
Table 222. Pharmaceutical Grade Melatonin Products Market Drivers
Table 223. Pharmaceutical Grade Melatonin Products Market Challenges
Table 224. Pharmaceutical Grade Melatonin Products Market Restraints
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
Table 228. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Grade Melatonin Products
Figure 2. Global Pharmaceutical Grade Melatonin Products Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Pharmaceutical Grade Melatonin Products Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Oral Solution Product Picture
Figure 6. Global Pharmaceutical Grade Melatonin Products Market Value by Source (US$ Million), 2021–2032
Figure 7. Global Pharmaceutical Grade Melatonin Products Market Share by Source: 2025 vs 2032
Figure 8. Natural Melatonin Product Picture
Figure 9. Synthetic Melatonin Product Picture
Figure 10. Global Pharmaceutical Grade Melatonin Products Market Value by Dosage Forms (US$ Million), 2021–2032
Figure 11. Global Pharmaceutical Grade Melatonin Products Market Share by Dosage Forms: 2025 vs 2032
Figure 12. Immediate-Release Tablets Product Picture
Figure 13. Sustained-Release Tablets Product Picture
Figure 14. Global Pharmaceutical Grade Melatonin Products Market Value by Application (US$ Million), 2021–2032
Figure 15. Global Pharmaceutical Grade Melatonin Products Market Share by Application: 2025 & 2032
Figure 16. Hospital and Clinic
Figure 17. Pharmacy
Figure 18. Other
Figure 19. Global Pharmaceutical Grade Melatonin Products Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Pharmaceutical Grade Melatonin Products Market Size (US$ Million), 2021–2032
Figure 21. Global Pharmaceutical Grade Melatonin Products Sales (K Units), 2021–2032
Figure 22. Global Pharmaceutical Grade Melatonin Products Average Price (US$/Unit), 2021–2032
Figure 23. Pharmaceutical Grade Melatonin Products Report Years Considered
Figure 24. Pharmaceutical Grade Melatonin Products Sales Share by Manufacturers in 2025
Figure 25. Global Pharmaceutical Grade Melatonin Products Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Pharmaceutical Grade Melatonin Products Players: Market Share by Revenue in Pharmaceutical Grade Melatonin Products in 2025
Figure 27. Pharmaceutical Grade Melatonin Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Pharmaceutical Grade Melatonin Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
Figure 30. North America Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
Figure 31. United States Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
Figure 34. Europe Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
Figure 35. Germany Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Pharmaceutical Grade Melatonin Products Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Pharmaceutical Grade Melatonin Products Revenue Market Share by Region (2021–2032)
Figure 42. China Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Southeast Asia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
Figure 50. Latin America Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Colombia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Pharmaceutical Grade Melatonin Products Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Pharmaceutical Grade Melatonin Products Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. UAE Pharmaceutical Grade Melatonin Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Pharmaceutical Grade Melatonin Products by Type (2021–2032)
Figure 61. Global Revenue Market Share of Pharmaceutical Grade Melatonin Products by Type (2021–2032)
Figure 62. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Sales Market Share of Pharmaceutical Grade Melatonin Products by Application (2021–2032)
Figure 64. Global Revenue Market Share of Pharmaceutical Grade Melatonin Products by Application (2021–2032)
Figure 65. Global Pharmaceutical Grade Melatonin Products Price (US$/Unit) by Application (2021–2032)
Figure 66. Pharmaceutical Grade Melatonin Products Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
